{
    "id": "34b8eaa6-bab6-a452-e063-6394a90aa461",
    "indications": {
        "text": "camcevi indicated treatment adult patients advanced prostate cancer .",
        "doid_entities": [
            {
                "text": "prostate cancer (DOID:10283)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10283"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "full prescribing information instructions preparation injectable emulsion pre-filled syringe . ( 2 ) recommended : 42 mg subcutaneously every 6 months . ( 2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "camcevi sterile , off-white pale yellow , viscous opalescent injectable emulsion supplied kit single-dose , pre-filled syringe . camcevi available follows : kit contents ndc injectable emulsion pre-filled syringe containing 42 mg leuprolide subcutaneous injection , sterile 18-gauge surguard \u00ae3 safety needle , prescribing information . 69448-023-63 store camcevi 2\u00b0c\u20138\u00b0c ( 36\u00b0f\u201346\u00b0f ) . protect camcevi light storing original package time . freeze shake . rubber used syringe tip cap plunger stopper made natural rubber latex .",
    "adverseReactions": "camcevi contraindicated patients known hypersensitive gnrh , gnrh agonist analogs , excipients camcevi . anaphylactic gnrh agonist analogs reported medical literature .",
    "ingredients": [
        {
            "name": "POLYLACTIDE",
            "code": "459TN2L5F5",
            "drugbank_id": "https://go.drugbank.com/drugs/DB15037"
        },
        {
            "name": "METHYLPYRROLIDONE",
            "code": "JR9CE63FPM",
            "drugbank_id": "https://go.drugbank.com/drugs/DB12521"
        },
        {
            "name": "LEUPROLIDE MESYLATE",
            "code": "8E3C3C493W",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6427"
        }
    ],
    "organization": "Accord BioPharma, Inc.",
    "name": "CAMCEVI",
    "effectiveTime": "20250509",
    "indications_original": "CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.",
    "contraindications_original": "See Full Prescribing Information for instructions on the preparation and administration of the injectable emulsion in a pre-filled syringe. ( 2 ) Recommended Dosage: 42 mg subcutaneously every 6 months. ( 2 )",
    "warningsAndPrecautions_original": "CAMCEVI is a sterile, off-white to pale yellow, viscous and opalescent injectable emulsion supplied in a kit as a single-dose, pre-filled syringe. CAMCEVI is available as follows:\n                  \n                     \n                     \n                     \n                        \n                           \n                              Kit Contents\n                           \n                           \n                              NDC\n                           \n                        \n                        \n                           \n                              Injectable emulsion in a pre-filled syringe containing 42 mg leuprolide for subcutaneous injection, a sterile 18-gauge SurGuard\n     \n      \u00ae3 safety needle, and Prescribing Information.\n    \n     \n                           \n                           \n                              69448-023-63\n                           \n                        \n                     \n                  \n                  Store CAMCEVI at 2\u00b0C\u20138\u00b0C (36\u00b0F\u201346\u00b0F). Protect CAMCEVI from light by storing in the original package until time of use. Do not freeze or shake.\n                  The rubber used in syringe tip cap and plunger stopper is not made of natural rubber latex.",
    "adverseReactions_original": "CAMCEVI is contraindicated in patients known to be hypersensitive to GnRH, GnRH agonist analogs, or any of the excipients in CAMCEVI. Anaphylactic reactions to GnRH agonist analogs have been reported in the medical literature.",
    "drug": [
        {
            "name": "CAMCEVI",
            "drugbank_id": "https://go.drugbank.com/drugs/DB15037"
        }
    ]
}